Costa R - Search Results

1

Ratto GB, Costa R, Alloisio A, Maineri P, Ceppa P, Chiaramondia M. Ratto GB, et al. Among authors: costa r. Tumori. 2004 Jan-Feb;90(1):151-3. doi: 10.1177/030089160409000131. Tumori. 2004. PMID: 15143991

2

Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.

Ratto GB, Costa R, Vassallo G, Alloisio A, Maineri P, Bruzzi P. Ratto GB, et al. Among authors: costa r. Ann Thorac Surg. 2004 Jul;78(1):234-7. doi: 10.1016/j.athoracsur.2004.01.023. Ann Thorac Surg. 2004. PMID: 15223435 Review.

3

Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?

Ratto GB, Costa R, Maineri P, Alloisio A, Bruzzi P, Dozin B. Ratto GB, et al. Among authors: costa r. J Thorac Cardiovasc Surg. 2009 Oct;138(4):849-58. doi: 10.1016/j.jtcvs.2009.03.017. Epub 2009 Jun 6. J Thorac Cardiovasc Surg. 2009. PMID: 19660370 Free article.

4

Primary peripheral adenoid cystic carcinoma of the lung. A case report.

Ratto GB, Alloisio A, Costa R, Chiaramondia M. Ratto GB, et al. Among authors: costa r. Acta Chir Belg. 2003 Aug;103(4):414-5. doi: 10.1080/00015458.2003.11679456. Acta Chir Belg. 2003. PMID: 14524164

5

Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study.

Ratto GB, Costa R, Maineri P, Alloisio A, Piras MT, D'Agostino A, Tripodi G, Rivabella L, Dozin B, Bruzzi P, Melioli G. Ratto GB, et al. Among authors: costa r. Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):1005-16. doi: 10.1177/039463201102400418. Int J Immunopathol Pharmacol. 2011. PMID: 22230406 Free article. Clinical Trial.

6

Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression.

Rotondo R, Mastracci L, Piazza T, Barisione G, Fabbi M, Cassanello M, Costa R, Morandi B, Astigiano S, Cesario A, Sormani MP, Ferlazzo G, Grossi F, Ratto GB, Ferrini S, Frumento G. Rotondo R, et al. Among authors: costa r. Int J Cancer. 2008 Sep 1;123(5):1108-16. doi: 10.1002/ijc.23437. Int J Cancer. 2008. PMID: 18528866

7

Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.

Semino C, Martini L, Queirolo P, Cangemi G, Costa R, Alloisio A, Ferlazzo G, Sertoli MR, Reali UM, Ratto GB, Melioli G. Semino C, et al. Among authors: costa r. Anticancer Res. 1999 Nov-Dec;19(6C):5645-9. Anticancer Res. 1999. PMID: 10697634 Review.

8

Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.

Grossi F, Loprevite M, Chiaramondia M, Ceppa P, Pera C, Ratto GB, Serrano J, Ferrara GB, Costa R, Boni L, Ardizzoni A. Grossi F, et al. Among authors: costa r. Eur J Cancer. 2003 Jun;39(9):1242-50. doi: 10.1016/s0959-8049(03)00232-6. Eur J Cancer. 2003. PMID: 12763212

9

Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer.

Ratto GB, Cafferata MA, Scolaro T, Bruzzi P, Alloisio A, Costa R, Spessa E, Semino C, Melioli G. Ratto GB, et al. Among authors: costa r. J Immunother. 2000 Jan;23(1):161-7. doi: 10.1097/00002371-200001000-00019. J Immunother. 2000. PMID: 10687149 Clinical Trial.

10

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.

Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G. Carrega P, et al. Among authors: costa r. Cancer. 2008 Feb 15;112(4):863-75. doi: 10.1002/cncr.23239. Cancer. 2008. PMID: 18203207 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,471 results

Search Page

Filters